title: Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice.
authors.forename: Laura
authors.initials: L
authors.lastname: Romano
authors.forename: Cecilia
authors.initials: C
authors.lastname: Peduzzi
authors.forename: Giulietta
authors.initials: G
authors.lastname: Venturi
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Pietro
authors.forename: Tiziana
authors.initials: T
authors.lastname: Carli
authors.forename: Paola
authors.initials: P
authors.lastname: Corsi
authors.forename: Angela
authors.initials: A
authors.lastname: Gonnelli
authors.forename: Pier E
authors.initials: PE
authors.lastname: Valensin
authors.forename: Maurizio
authors.initials: M
authors.lastname: Zazzi
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D016333:HIV Protease / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D061466:Lopinavir; D009154:Mutation; D011744:Pyrimidinones / Q000494:pharmacology / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D019438:Ritonavir / Q000494:pharmacology / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D061466:Lopinavir; D016333:HIV Protease; D019438:Ritonavir